Literature DB >> 15851979

Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients.

Nicole Weisschuh1, Dorit Neumann, Christiane Wolf, Bernd Wissinger, Eugen Gramer.   

Abstract

PURPOSE: To determine the prevalence of optineurin (OPTN) and myocilin (MYOC) sequence variants in a cohort of German patients with normal tension glaucoma.
METHODS: All coding exons of the OPTN and MYOC genes were amplified by PCR from genomic DNA and subjected to direct DNA sequencing. Analysis of sequence variants in controls was done by denaturing high performance liquid chromatography (DHPLC) and restriction fragment length polymorphism (RFLP) analysis.
RESULTS: Sequence variants were identified by DNA sequencing in 10 of 112 cases. The OPTN sequence variant M98K was found in seven patients. In addition, two novel sequence variants (A336G and A377T) in the OPTN gene were identified that were not present in a control group. Mutation screening also identified two potentially pathogenic MYOC mutations (T293K and A445V).
CONCLUSIONS: The findings in the current study provide further evidence that MYOC and OPTN gene variants are rare causes of NTG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851979

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  28 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Primary open-angle glaucoma genes.

Authors:  J H Fingert
Journal:  Eye (Lond)       Date:  2011-05       Impact factor: 3.775

3.  [Morphology, family history, and age at diagnosis of 26 patients with Axenfeld-Rieger syndrome and glaucoma or ocular hypertension].

Authors:  P Dressler; E Gramer
Journal:  Ophthalmologe       Date:  2006-05       Impact factor: 1.059

4.  The role of the Met98Lys optineurin variant in inherited optic nerve diseases.

Authors:  J E Craig; A W Hewitt; D P Dimasi; N Howell; C Toomes; A C Cohn; D A Mackey
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

5.  Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice.

Authors:  Zai-Long Chi; Masakazu Akahori; Minoru Obazawa; Masayoshi Minami; Toru Noda; Naoki Nakaya; Stanislav Tomarev; Kazuhide Kawase; Tetsuya Yamamoto; Setsuko Noda; Masaki Sasaoka; Atsushi Shimazaki; Yuichiro Takada; Takeshi Iwata
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

6.  Screening of CYP1B1 and MYOC in Moroccan families with primary congenital glaucoma: three novel mutations in CYP1B1.

Authors:  Latifa Hilal; Soraya Boutayeb; Aziza Serrou; Loubna Refass-Buret; Hafsa Shisseh; Fatiha Bencherifa; Mohammed El Mzibri; Bouchra Benazzouz; Amina Berraho
Journal:  Mol Vis       Date:  2010-07-02       Impact factor: 2.367

7.  Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma.

Authors:  Yutao Liu; Stephen Akafo; Cecile Santiago-Turla; Claudia S Cohen; Karen R Larocque-Abramson; Xuejun Qin; Leon W Herndon; Pratap Challa; Silke Schmidt; Michael A Hauser; R Rand Allingham
Journal:  Mol Vis       Date:  2008-12-18       Impact factor: 2.367

8.  Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study.

Authors:  Christiane Wolf; Eugen Gramer; Bertram Müller-Myhsok; Francesca Pasutto; Eva Reinthal; Bernd Wissinger; Nicole Weisschuh
Journal:  BMC Med Genet       Date:  2009-09-15       Impact factor: 2.103

9.  Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma.

Authors:  Chun Yuan Wang; Ying-Cheng Shen; Chien-Hui Su; Fai-Yun Lo; Shi-Huang Lee; Hin-Yeung Tsai; Seng-Sheen Fan
Journal:  Mol Vis       Date:  2007-05-14       Impact factor: 2.367

10.  Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients.

Authors:  Arun Kumar; Manjunath G Basavaraj; Santosh K Gupta; Imteyaz Qamar; Abdullah Mahmood Ali; Vineeta Bajaj; T K Ramesh; D Ravi Prakash; Jyoti S Shetty; Syril K Dorairaj
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.